• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NUB1表达降低通过干扰肝癌细胞中PCNA的多聚泛素化/类泛素化修饰促进PCNA介导的肿瘤生长。

NUB1 reduction promotes PCNA-mediated tumor growth by disturbing the PCNA polyubiquitination/NEDDylation in hepatocellular carcinoma cells.

作者信息

Du Dongnian, Zhang Wenming, Zhang Dandan, Liu Lingpeng, Li Jiajuan, Chen Zehao, Yu Xuzhe, Ye Miao, Wang Wei, Li Zijing, Shao Jianghua

机构信息

Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, 330000, China.

Jiangxi Province Key Laboratory of Molecular Medicine, Second Affiliated Hospital of Nanchang University, Nanchang, 330000, China.

出版信息

Cell Death Dis. 2025 Mar 31;16(1):228. doi: 10.1038/s41419-025-07567-3.

DOI:10.1038/s41419-025-07567-3
PMID:40164590
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11958677/
Abstract

Negative regulator of ubiquitin-like protein 1 (NUB1), an inhibitor of neural precursor cells expressed developmentally downregulated 8 (NEDD8), is implicated in tumor growth. However, the expression of NUB1 in hepatocellular carcinoma (HCC) and its effects on HCC growth remain unclear. In this study, our findings revealed reduced NUB1 protein expression in HCC tissues and cells, leading to increased proliferating cell nuclear antigen (PCNA) protein stability through upregulating NEDD8 to promote HCC cell growth. Mechanistically, NUB1 reduction upregulated NEDD8 to promote PCNA NEDDylation at lysine 164 (Lys164), in turn, antagonized PCNA K48-linked polyubiquitination, thereby increasing the stability of PCNA in HCC cells. Finally, the results of the in vitro and in vivo experiments revealed that the NEDDylation inhibitor TAS4464 could inhibit PCNA NEDDylation to decrease PCNA protein expression, thereby suppressing HCC cell growth. Collectively, our results identified NUB1 as a negative regulator of HCC proliferation and confirmed that PCNA NEDDylation promotes PCNA protein stability by antagonizing PCNA polyubiquitination. This study provides a new perspective on the specific mechanism of HCC growth. It expands our understanding of the role of NEDDylation in the regulation of substrate proteins and their functions.

摘要

泛素样蛋白1负调节因子(NUB1)是神经前体细胞表达的发育性下调蛋白8(NEDD8)的抑制剂,与肿瘤生长有关。然而,NUB1在肝细胞癌(HCC)中的表达及其对HCC生长的影响仍不清楚。在本研究中,我们的发现揭示了HCC组织和细胞中NUB1蛋白表达降低,通过上调NEDD8导致增殖细胞核抗原(PCNA)蛋白稳定性增加,从而促进HCC细胞生长。机制上,NUB1表达降低上调NEDD8,促进PCNA在赖氨酸164(Lys164)位点的NEDD化,进而拮抗PCNA的K48连接的多聚泛素化,从而增加HCC细胞中PCNA的稳定性。最后,体外和体内实验结果表明,NEDD化抑制剂TAS4464可抑制PCNA的NEDD化以降低PCNA蛋白表达,从而抑制HCC细胞生长。总的来说,我们的结果确定NUB1是HCC增殖的负调节因子,并证实PCNA的NEDD化通过拮抗PCNA的多聚泛素化促进PCNA蛋白稳定性。本研究为HCC生长的具体机制提供了新的视角。它扩展了我们对NEDD化在调节底物蛋白及其功能中的作用的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f905/11958677/927bd7308b1a/41419_2025_7567_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f905/11958677/a05554852996/41419_2025_7567_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f905/11958677/4556211dad78/41419_2025_7567_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f905/11958677/0729dd314f81/41419_2025_7567_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f905/11958677/a5dabb396904/41419_2025_7567_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f905/11958677/2db9e9291a66/41419_2025_7567_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f905/11958677/cbaa15396387/41419_2025_7567_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f905/11958677/36f8e4ef198b/41419_2025_7567_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f905/11958677/927bd7308b1a/41419_2025_7567_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f905/11958677/a05554852996/41419_2025_7567_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f905/11958677/4556211dad78/41419_2025_7567_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f905/11958677/0729dd314f81/41419_2025_7567_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f905/11958677/a5dabb396904/41419_2025_7567_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f905/11958677/2db9e9291a66/41419_2025_7567_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f905/11958677/cbaa15396387/41419_2025_7567_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f905/11958677/36f8e4ef198b/41419_2025_7567_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f905/11958677/927bd7308b1a/41419_2025_7567_Fig8_HTML.jpg

相似文献

1
NUB1 reduction promotes PCNA-mediated tumor growth by disturbing the PCNA polyubiquitination/NEDDylation in hepatocellular carcinoma cells.NUB1表达降低通过干扰肝癌细胞中PCNA的多聚泛素化/类泛素化修饰促进PCNA介导的肿瘤生长。
Cell Death Dis. 2025 Mar 31;16(1):228. doi: 10.1038/s41419-025-07567-3.
2
Heat-Shock protein A12A is a novel PCNA-binding protein and promotes hepatocellular carcinoma growth.热休克蛋白 A12A 是一种新型 PCNA 结合蛋白,可促进肝癌生长。
FEBS J. 2020 Dec;287(24):5464-5477. doi: 10.1111/febs.15276. Epub 2020 Mar 25.
3
NEDDylation antagonizes ubiquitination of proliferating cell nuclear antigen and regulates the recruitment of polymerase η in response to oxidative DNA damage.NEDDylation 拮抗增殖细胞核抗原的泛素化,调节聚合酶 η 的募集以响应氧化 DNA 损伤。
Protein Cell. 2018 Apr;9(4):365-379. doi: 10.1007/s13238-017-0455-x. Epub 2017 Aug 22.
4
Inhibition of neddylation modification by MLN4924 sensitizes hepatocellular carcinoma cells to sorafenib.MLN4924 通过抑制 neddylation 修饰增强肝癌细胞对索拉非尼的敏感性。
Oncol Rep. 2019 Jun;41(6):3257-3269. doi: 10.3892/or.2019.7098. Epub 2019 Apr 4.
5
Kruppel-like factor 6 suppresses growth and invasion of hepatocellular carcinoma cells in vitro and in vivo.Kruppel样因子6在体外和体内均抑制肝癌细胞的生长和侵袭。
Int J Immunopathol Pharmacol. 2016 Dec;29(4):666-675. doi: 10.1177/0394632016655171. Epub 2016 Aug 10.
6
The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.趋化因子受体 CCR10 通过激活 PI3K/Akt 通路促进炎症驱动的肝癌发生。
Cell Death Dis. 2018 Feb 14;9(2):232. doi: 10.1038/s41419-018-0267-9.
7
Antisense long non-coding RNA PCNA-AS1 promotes tumor growth by regulating proliferating cell nuclear antigen in hepatocellular carcinoma.反义长非编码 RNA PCNA-AS1 通过调控肝癌细胞增殖细胞核抗原促进肿瘤生长。
Cancer Lett. 2014 Jul 10;349(1):87-94. doi: 10.1016/j.canlet.2014.03.029. Epub 2014 Apr 2.
8
UBC12-mediated SREBP-1 neddylation worsens metastatic tumor prognosis.UBC12 介导的 SREBP-1 泛素化加重转移性肿瘤预后不良。
Int J Cancer. 2020 Nov 1;147(9):2550-2563. doi: 10.1002/ijc.33113. Epub 2020 Jun 23.
9
HDM2 Promotes NEDDylation of Hepatitis B Virus HBx To Enhance Its Stability and Function.HDM2促进乙型肝炎病毒HBx的NEDD化修饰以增强其稳定性和功能。
J Virol. 2017 Jul 27;91(16). doi: 10.1128/JVI.00340-17. Print 2017 Aug 15.
10
Ajuba inhibits hepatocellular carcinoma cell growth via targeting of β-catenin and YAP signaling and is regulated by E3 ligase Hakai through neddylation.Ajuba 通过靶向 β-catenin 和 YAP 信号抑制肝癌细胞生长,并且受到 E3 连接酶 Hakai 通过 neddylation 进行调控。
J Exp Clin Cancer Res. 2018 Jul 24;37(1):165. doi: 10.1186/s13046-018-0806-3.

引用本文的文献

1
Mechanism and Predictive Role of NUB1 Protein in Oestrogen Receptor Pathway of FEC-Treated Breast Cancer Patients.NUB1蛋白在FEC治疗的乳腺癌患者雌激素受体通路中的作用机制及预测作用
Biomedicines. 2025 May 27;13(6):1307. doi: 10.3390/biomedicines13061307.

本文引用的文献

1
EIF3B stabilizes PCNA by counteracting SYVN1-mediated ubiquitination to serve as a promotor in cholangiocarcinoma.EIF3B 通过拮抗 SYVN1 介导的泛素化稳定 PCNA,从而在胆管癌中作为一个促进子发挥作用。
Aging (Albany NY). 2024 Apr 29;16(8):7311-7330. doi: 10.18632/aging.205759.
2
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
3
Dysregulated NUB1 and Neddylation Enhances Rheumatoid Arthritis Fibroblast-Like Synoviocyte Inflammatory Responses.
失调的 NUB1 和 Neddylation 增强类风湿关节炎成纤维样滑膜细胞的炎症反应。
Arthritis Rheumatol. 2024 Aug;76(8):1252-1262. doi: 10.1002/art.42856. Epub 2024 Jun 5.
4
Control of protein stability by post-translational modifications.蛋白质翻译后修饰对其稳定性的调控。
Nat Commun. 2023 Jan 13;14(1):201. doi: 10.1038/s41467-023-35795-8.
5
Hepatocellular carcinoma.肝细胞癌
Lancet. 2022 Oct 15;400(10360):1345-1362. doi: 10.1016/S0140-6736(22)01200-4. Epub 2022 Sep 6.
6
LncRNA GASAL1 promotes hepatocellular carcinoma progression by up-regulating USP10-stabilized PCNA.长链非编码 RNA GASAL1 通过上调 USP10 稳定的 PCNA 促进肝癌进展。
Exp Cell Res. 2022 Jun 1;415(1):112973. doi: 10.1016/j.yexcr.2021.112973. Epub 2021 Dec 14.
7
NUB1 and FAT10 Proteins as Potential Novel Biomarkers in Cancer: A Translational Perspective.NUB1 和 FAT10 蛋白作为癌症潜在的新型生物标志物:转化视角。
Cells. 2021 Aug 24;10(9):2176. doi: 10.3390/cells10092176.
8
Proliferating cell nuclear antigen (PCNA) overexpression in hepatocellular carcinoma predicts poor prognosis as determined by bioinformatic analysis.通过生物信息学分析确定,增殖细胞核抗原(PCNA)在肝细胞癌中的过表达预示着预后不良。
Chin Med J (Engl). 2020 Nov 3;134(7):848-850. doi: 10.1097/CM9.0000000000001192.
9
TAS4464, a NEDD8-activating enzyme inhibitor, activates both intrinsic and extrinsic apoptotic pathways via c-Myc-mediated regulation in acute myeloid leukemia.TAS4464是一种NEDD8激活酶抑制剂,它通过c-Myc介导的调节作用激活急性髓系白血病中的内源性和外源性凋亡途径。
Oncogene. 2021 Feb;40(7):1217-1230. doi: 10.1038/s41388-020-01586-4. Epub 2021 Jan 8.
10
Neddylation inhibitor MLN4924 has anti-HBV activity via modulating the ERK-HNF1α-C/EBPα-HNF4α axis.Neddylation 抑制剂 MLN4924 通过调节 ERK-HNF1α-C/EBPα-HNF4α 轴发挥抗 HBV 活性。
J Cell Mol Med. 2021 Jan;25(2):840-854. doi: 10.1111/jcmm.16137. Epub 2020 Dec 2.